Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824158 · ClinicalTrials.gov registry record · NA

Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial

A NA study of Cancer and Advance Care Planning, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
672
Enrollment target
1
Study location

NCT03824158: Completed NA study of Cancer and Advance Care Planning, sponsored by University of Pittsburgh.

NCT03824158 is a NA study of Cancer and Advance Care Planning that has completed, run by University of Pittsburgh. The registered enrollment target is 672 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824158, a NA study of Cancer and Advance Care Planning, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
672 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to identify the most effective and efficient advance care planning (ACP) strategy for patients with advanced cancer. The specific aims are to: Aim 1. Compare the effectiveness of in-person, facilitated ACP versus web-based ACP on patient and family caregiver outcomes. Aim 2. Assess implementation costs and the effects of in-person, facilitated ACP and web-based ACP on healthcare utilization at end of life. Aim 3. Identify contexts and mechanisms that influence the effectiveness of in-person, facilitated ACP versus web-based ACP.

Primary Outcome

15-item Advance Care Planning (ACP) engagement survey assesses ACP processes related to choosing a medical decision maker, discussing and documenting preference for care at end of life, flexibility for surrogate decision making, and asking questions of medical providers. A single summary score will be reported (range 0-5 with higher scores indicating higher engagement).

Interventions

  • BEHAVIORAL Facilitated advance care planning (in-person or telephonic)
  • BEHAVIORAL Web-based advance care planning

Study Locations (1)

Pennsylvania

  • UPMC Hillman Cancer Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 672 participants
Start Date 2019-08-01
Est. Completion 2025-07-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03824158 record still lists

NCT03824158 is an interventional study that assigns participants to a tested intervention. The registered 672 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Facilitated advance care planning (in-person or telephonic) is the first listed.

NCT03824158 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03824158 about?

NCT03824158 is a clinical study titled "Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial". The overall goal of this study is to identify the most effective and efficient advance care planning (ACP) strategy for patients with advanced cancer. The specific aims are to: Aim 1. Compare the effectiveness of in-person, facilitated ACP versus web-based ACP on patient and family caregiver outco...

What is the current status of trial NCT03824158?

This trial is currently completed. It is a NA study. The enrollment target is 672 participants. The study started on 2019-08-01. Estimated completion is 2025-07-30.

What conditions does trial NCT03824158 study?

This clinical trial studies the following conditions: Cancer, Advance Care Planning.

What interventions are being tested in trial NCT03824158?

The interventions under investigation include: Facilitated advance care planning (in-person or telephonic) (BEHAVIORAL), Web-based advance care planning (BEHAVIORAL).

Who is sponsoring clinical trial NCT03824158?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03824158 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03824158's enrollment target sits among peer trials

672 106th of 615 higher than 510 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452031 · 672 participants · NA

    A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

  • NCT05493254 · 672 participants · NA

    Enhancing Smoking Cessation Via Telehealth Options in Primary Care

  • NCT06651086 · 672 participants · NA

    Hybrid Effectiveness-Implementation Trial of an Executive Functioning Intervention for Children's Mental Health Services

  • NCT07184944 · 671 participants · Phase 3

    A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03824158, the US trial registry maintained by the National Library of Medicine. NCT03824158 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.